[1]Carstensen;Kothari[JournalofPharmaceuticalSciences,1981,vol.70,#10,p.1095-1100]
[2]CurrentPatentAssignee:SANOFI-US4980371,1990,A
[3]CurrentPatentAssignee:SANOFI-US4602099,1986,A
[1]Carstensen;Kothari[JournalofPharmaceuticalSciences,1980,vol.69,#1,p.123-124]
[1]Carstensen;Kothari[JournalofPharmaceuticalSciences,1981,vol.70,#10,p.1095-1100]
Title: The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.
Journal: Molecular cancer therapeutics 20120301
Title: Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor.
Journal: Oncotarget 20120201
Title: Metabolic regulation of invadopodia and invasion by acetyl-CoA carboxylase 1 and de novo lipogenesis.
Journal: PloS one 20120101
Title: SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids.
Journal: PloS one 20120101
Title: Supplementation of pyruvate prevents palmitate-induced impairment of glucose uptake in C2 myotubes.
Journal: Molecular and cellular endocrinology 20111015
Title: The lipogenesis pathway as a cancer target.
Journal: Journal of medicinal chemistry 20110825
Title: TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status.
Journal: Cancer biology & therapy 20110701
Title: Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.
Journal: PLoS pathogens 20110701
Title: Hypothalamic Angptl4/Fiaf is a novel regulator of food intake and body weight.
Journal: Diabetes 20101101
Title: Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+.
Journal: The Journal of biological chemistry 20100108
Title: Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis.
Journal: Biochemical and biophysical research communications 20090731
Title: De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy.
Journal: British journal of cancer 20090505
Title: Legionella pneumophila couples fatty acid flux to microbial differentiation and virulence.
Journal: Molecular microbiology 20090301
Title: Effect of centrally administered C75, a fatty acid synthase inhibitor, on gastric emptying and gastrointestinal transit in mice.
Journal: European journal of pharmacology 20081024
Title: Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism.
Journal: The Journal of biological chemistry 20080523
Title: 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20080201
Title: Expression, purification, and characterization of human acetyl-CoA carboxylase 2.
Journal: Protein expression and purification 20070501
Title: Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
Journal: Cancer research 20070401
Title: Fatty acid synthase: a novel target for antiglioma therapy.
Journal: British journal of cancer 20061009
Title: Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels.
Journal: Endocrinology 20060801
Title: Nutritional status influences socially regulated foraging ontogeny in honey bees.
Journal: The Journal of experimental biology 20051201
Title: Cross-talk between an activator of nuclear receptors-mediated transcription and the D1 dopamine receptor signaling pathway.
Journal: Pharmacology, biochemistry, and behavior 20050301
Title: Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Journal: Cancer research 20031101
Title: Leptin receptor-deficient obese Zucker rats reduce their food intake in response to a systemic supply of calories from glucose.
Journal: Diabetes 20030201
Title: Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity.
Journal: Biochemical and biophysical research communications 20010713
Title: Wang C, et al. Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. Biochem Biophys Res Commun. 2009 Jul 31;385(3):302-6.
Title: Li S, et al. TOFA suppresses ovarian cancer cell growth in vitro and in vivo. Mol Med Rep. 2013 Aug;8(2):373-8.
Title: Guseva NV, et al. TOFA (5-tetradecyl-oxy-2-furoic acid) reduces fatty acid synthesis, inhibits expression of AR, neuropilin-1 and Mcl-1 and kills prostate cancer cells independent of p53 status. Cancer Biol Ther. 2011 Jul 1;12(1):80-5.
